| Literature DB >> 28130493 |
Kimberley D Gutierrez1, Michael A Davis1, Brian P Daniels1, Tayla M Olsen1, Pooja Ralli-Jain1, Stephen W G Tait2, Michael Gale1,3, Andrew Oberst4,3.
Abstract
Necroptosis is a form of programmed cell death defined by activation of the kinase receptor interacting protein kinase 3 and its downstream effector, the pseudokinase mixed lineage kinase domain-like (MLKL). Activated MLKL translocates to the cell membrane and disrupts it, leading to loss of cellular ion homeostasis. In this study, we use a system in which this event can be specifically triggered by a small-molecule ligand to show that MLKL activation is sufficient to induce the processing and release of bioactive IL-1β. MLKL activation triggers potassium efflux and assembly of the NLRP3 inflammasome, which is required for the processing and activity of IL-1β released during necroptosis. Notably, MLKL activation also causes cell membrane disruption, which allows efficient release of IL-1β independently of the recently described pyroptotic effector gasdermin-D. Taken together, our findings indicate that MLKL is an endogenous activator of the NLRP3 inflammasome, and that MLKL activation provides a mechanism for concurrent processing and release of IL-1β independently of gasdermin-D.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28130493 PMCID: PMC5321867 DOI: 10.4049/jimmunol.1601757
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422